J.P. Morgan Chase & Co. has a Neutral rating and is raising its price target to $12 from $10 on shares of Skilled Healthcare Group, Inc. SKH.
In a note sent to clients, J.P. Morgan writes, "We are raising our yearend price target to $12 from our prior target of $10 on the better than expected 2011 outlook resulting from RUG-IV performance. Under an OpCo/PropCo valuation, we estimate the shares could be valued in the low teens and potentially higher which should continue to help provide support. The recent HCP/ManorCare sale/leaseback transaction and Sun Healthcare REIT conversion highlighted the embedded real estate value of the company which had been an under appreciated option in the shares."
Shares of SKH gained $1.13 yesterday to close at $10.66, a gain of over 11%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in